Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts

Part of paid clinical trials in Baltimore, Maryland.

Sponsor
Johns Hopkins University
Study ID
NCT04473794
Status
Recruiting
Apply to this trial

Conditions

  • Pancreas Cancer
  • Pancreatic Neoplasms

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The aims of this study are to determine the natural history of pancreatic cysts and to propose and prospectively validate a diagnostic approach and model for prediction of mucinous versus non-mucinous, and malignant versus non-malignant, pancreatic cysts using a combination of clinical, radiologic, and biomarker characteristics.

Key Dates

Start date
Jul 20, 2022
Status verified
Feb 2026
Primary completion
Nov 1, 2035
Completion
Aug 1, 2036

Study Design

Enrollment
5,000 participants (estimated)

Primary Outcome Measure

Clinical utility of Compcyst in pancreatic cysts as assessed by patient chart review [ Time Frame: 15 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
The Johns Hopkins HospitalBaltimoreMaryland21287
Elham Afghani, MD MPH
[email protected]
410-614-6708
Vaishnavi S Sawant, MBBS MPH
[email protected]
443-603-5875

Find similar trials in Baltimore, MD

By research site
The Johns Hopkins Hospital· Baltimore, MD

Related Studies